argenx SE

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

  • Registration date 01 nov 2018 - 14:15
  • Statutory name argenx SE
  • Title argenx announces new cusatuzumab (ARGX-110) AML data in abstracts published in connection with 60th American Society of Hematology Annual Meeting and Exposition

Related downloads

201811010000000025_Press Release (PDF).pdf

Date last update: 22 October 2019

Share information

Share on: Share this